Virtual Medicinal Product (VMP) - Magnesium hydroxide 7.45-8.35% oral suspension BP
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Magnesium hydroxide 7.45-8.35% oral suspension BP | Start Date 01-04-2017 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- Other
Codes
- ATC Code
- A02AA04
- BNF Codes
-
- BNF code 01010100
| Code | Start Date | End Date |
|---|---|---|
| 34309111000001101 | 01-04-2017 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Magnesium hydroxide | Based on Ingredient Substance | 79 mg | 1 ml |
Name
Magnesium hydroxide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
79
Strength and UOM (Dmr)
1
Parent Products
-
VTMMagnesium hydroxide
-
VMP(Current) Magnesium hydroxide 7.45-8.35% oral ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 200 ml | 420 | Part VIIIA Category C |
| 500 ml |